Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Invivyd, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 200K | Dec 18, 2023 | Direct | ||
Kaleido Biosciences, Inc. | Chief Financial Officer | Restricted Stock Units | 125K | Jan 14, 2022 | Direct | ||
Apexigen, Inc. | Chief Financial Officer | Common Stock | 0 | $0.39 | Aug 23, 2023 | Direct | |
Apexigen, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 0 | Aug 23, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IVVD | Invivyd, Inc. | Dec 18, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Chief Financial Officer |
IVVD | Invivyd, Inc. | Sep 1, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Chief Financial Officer |
IVVD | Invivyd, Inc. | Sep 1, 2023 | 0 | $0 | 3 | Sep 5, 2023 | Chief Financial Officer |
APGN | Apexigen, Inc. | Aug 23, 2023 | 3 | -$10.2K | 4 | Aug 25, 2023 | Chief Financial Officer |
APGN | Apexigen, Inc. | Jun 15, 2023 | 1 | -$2.21K | 4 | Jun 23, 2023 | Chief Financial Officer |
APGN | Apexigen, Inc. | May 23, 2023 | 2 | -$6.9K | 4 | May 25, 2023 | Chief Financial Officer |
APGN | Apexigen, Inc. | Dec 15, 2022 | 1 | -$4.77K | 4 | Dec 19, 2022 | Chief Financial Officer |
APGN | Apexigen, Inc. | Oct 7, 2022 | 2 | $0 | 4 | Oct 11, 2022 | Chief Financial Officer |
APGN | Apexigen, Inc. | Jul 29, 2022 | 0 | $0 | 3 | Aug 8, 2022 | Chief Financial Officer |
KLDO | Kaleido Biosciences, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Chief Financial Officer |
KLDO | Kaleido Biosciences, Inc. | Sep 1, 2021 | 1 | $0 | 4 | Sep 2, 2021 | Chief Financial Officer |